Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells

Transplantation

Volumn 61, Issue 1, 1996, Pages 125-132

  Lee, Lorri A ^a   Sergio, Justin J ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 4; OKT 8;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTYPE SUPPRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; IMMUNOPATHOGENESIS; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE DEPLETION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030040954     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601150-00024     Document Type: Article

References (47)

1. Boyse EA. The fate of mouse spleen cells transplanted into homologous and Fl hybrid hosts. Immunology 1959; 2: 170.
2. Cudkowicz G. Evidence for immunization of F1 hybrid mice against parental transplantation antigens. Proc Soc Exp Biol Med 1961; 107: 968.
3. Celada F, Welshons WJ. Demonstration of F1 hybrid anti-parent immunological reaction. Proc Natl Acad Sci USA 1962; 48: 326.
4. McCulloch EA, Till JE. Repression of colony-forming ability of C57BL hematopoietic cells transplanted into nonisologous hosts. J Cell Comp Physiol 1963; 61: 301.
5. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 1971; 134: 83.
6. Cudkowicz G, Stimpfling JH. Deficient growth of C57BL mouse marrow cells transplanted in F1 hybrid mice. Association with the histocompatibility-2 locus. Immunology 1964; 7: 291.
7. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med 1971; 134: 1513.
8. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5: 117.
9. Kiessling R, Klein E, Pross H, Wigzell H. Natural killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of killer cells. Eur J Immunol 1975; 5: 117.
10. Rembecki RM, Kumar V, David CS, Bennett M. Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus. Immunogenetics 1988; 28: 158.
11. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1993; 10: 189.
12. Yankelevich B, Knobloch C, Nowicki M, Dennert G. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol 1989; 142: 3423.
13. Uchida N, Aguila HL, Fleming WH, Jerabek L, Weissmann IL. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca1+ hematopoietic stem cells. Blood 1994; 83: 3758.
14. Li CL, Johnson GR. Rhodamine 123 reveals heterogeneity within murine Lin-, Sca-1+ hematopoietic stem cells. J Exp Med 1992; 1443: 175.
15. Spangrude GJ, Johnson GR. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87: 7433.
16. Orlic D, Bodine DM. What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC please stand up. Blood 1994; 84: 3991.
17. Ferrara JLM, Mauch P, van Dijken PJ, Crosier KE, Michaelson J, Burakoff SJ. Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients. Transplantation 1990; 49: 134.
18. Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J Immunol 1988; 141: 2282.
19. Sykes M, Chester CH, Sundt TM, Romick ML, Hoyles KA, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients. J Immunol 1989; 143: 3503.
20. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989; 169: 493.
21. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to human Leu3/T4 molecule. J Immunol 1983; 131: 2445.
22. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665.
23. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087.
24. + cell lines. Cell Immunol 1990; 129: 478.
25. Koo GC, Peppard JR. Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma 1984; 3: 301.
26. d antigens on the surface of these cells. Transplantation 1982; 34: 113.
27. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994; 83: 939.
28. + cells. J Immunol 1990; 145: 3209.
29. Uchida N, Fleming WH, Alpern EJ, Weissman IL. Heterogeneity of hematopoietic stem cells. Curr Opin Immunol 1993; 5: 177.
30. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 1990; 4: 220.
31. b. J Immunol 1981; 126: 545.
32. Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992; 9: 191.
33. Sharabi Y, Sachs DH, Sykes M. T cell subsets resisting induction of mixed chimerism across various histocompatibility barriers. In: Proceedings of the 8th International Congress on Immunology. Heidelberg, Germany: Springer-Verlag. 1992: 801.
34. Anegon I, Cuturi MC, Trinchieri G, Perussia B. Interaction of Fc receptor (CD16) with ligands induces transcription of IL-2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988; 167: 452.
35. Clerigue M, Pisa P, Tsai L, Hanson M. Effects of interleukin-2 activated cells on in vitro myelopoiesis. Clin Exp Immunol 1990; 81: 459.
36. Hansson M, Petersson M, Koo GC, Wigzell H, Kiessling R. In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen. Eur J Immunol 1988; 18: 485.
37. Fujimori Y, Hara H, Nagai K. Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells. Cancer Res 1988; 48: 534.
38. Murphy WJ, Keller JR, Harrison ClL, Young HA, Longo DL. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo. Blood 1992; 80: 670.
39. Tiberghien P, Longo DL, Wine JW, Alvord WG, Reynolds CW. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 1990; 76: 1419.
40. Blazar BR, Soderling CCB, Koo GC, Vallera DA. Absence of a facilitory role for NK1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice. Transplantation 1988; 45: 876.
41. Johnson BD, Truitt RL. A decrease in graft-vs-host disease without loss of graft-vs-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplantation 1992; 54: 104.
42. Koo GC, Dumont FJ, Tutt M, Hackett J Jr, Kumar V. The NK1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol 1986; 137: 3742.
43. Kikly K, Dennert G. Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. TCR Vβ5 transgenic mice lack effector cells able to cause graft rejection. J Immunol 1992; 149: 3489.
44. Takeda K, Moore MW, Dennert G. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process. J Immunol 1994; 152: 4407.
45. + IL-2-activated natural killer cells. Nature 1992; 358: 66.
46. Sykes M, Harty MW, Karlhofer FM, Pearson DA, Szot G, Yokoyama W. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med 1993; 178: 223.
47. O'Reilly RJ, Brochstein J, Collins N, et al. Evaluation of HLA-haplotye disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang 1986; 51 (suppl 2) : 81.